Compare BY & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BY | NEOG |
|---|---|---|
| Founded | 1914 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2017 | 1995 |
| Metric | BY | NEOG |
|---|---|---|
| Price | $38.11 | $11.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $36.00 | $10.67 |
| AVG Volume (30 Days) | 209.4K | ★ 2.2M |
| Earning Date | 04-23-2026 | 04-09-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | 5.09 | ★ 99.20 |
| EPS | ★ 1.73 | N/A |
| Revenue | N/A | ★ $870,400,000.00 |
| Revenue This Year | $16.89 | N/A |
| Revenue Next Year | $3.15 | N/A |
| P/E Ratio | $22.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.57 | $4.90 |
| 52 Week High | $40.03 | $12.85 |
| Indicator | BY | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 56.74 |
| Support Level | $38.31 | $8.86 |
| Resistance Level | $38.86 | $12.85 |
| Average True Range (ATR) | 0.57 | 0.39 |
| MACD | -0.20 | -0.06 |
| Stochastic Oscillator | 29.70 | 42.34 |
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.